Publications Toxicology

Mayrhofer M, Kultima HG, Birgisson H, Sundström M, Mathot L, Edlund K, Viklund B, Sjöblom T, Botling J, Micke P, Påhlman L, Glimelius G, Isaksson A:

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer. BMC Cancer 14: 872 (2014) (9 pp)

Mattsson JSM, Bergman B, Grinberg M, Edlund K, Marincevic M, Jirström K, Pontén F, Hengstler JG, Rahnenführer J, Karlsson MG, Karlsson C, Helenius G, Botling J, Micke P, Gulyas M:

Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression. Cancer Lett 356: 837-845 (2014)

Ali N, Blaszkewicz M, Manirujjaman M, Perveen R, Al Nahid A, Mahmood S, Rahman M, Hossain K, Degen GH:

Biomonitoring of ochratoxin A in blood plasma and exposure assessment of adult students in Bangladesh. Mol Nutr Food Res 58: 2219-2225 (2014)

Abdel-Wareth AAA, Hammad S, Ahmed H:

Effects of Khaya senegalensis leaves on performance, carcass traits, hematological and biochemical parameters in rabbits. EXCLI J 13: 502-512 (2014)

Noguchi S, Saito A, Horie M, Mikami Y, Suzuki HI, Morishita Y, Ohshima M, Abiko Y, Mattsson JS, König H, Lohr M, Edlund K, Botling J, Micke P, Nagase T:

An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer. Clin Cancer Res 20: 4660-4672 (2014)

Micke P, Mattsson JS, Edlund K, Lohr M, Jirström K, Berglund A, Botling J, Rahnenfuehrer J, Marincevic M, Pontén F, Ekman S, Hengstler J, Wöll S, Sahin U, Türeci O:

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Int J Cancer 135: 2206-2214 (2014)

Sicking I, Edlund K, Wesbuer E, Weyer V, Battista MJ, Lebrecht A, Solbach C, Grinberg M, Lotz J, Hoffmann G, Rahnenführer J, Hengstler JG, Schmidt M:

Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients. PLoS One 9(10): e111306 (2014) (9 pp)

Drasdo D, Hoehme S, Hengstler JG:

How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis. J Hepatol 61: 951-956 (2014)

Weng MK, Natarajan K, Scholz D, Ivanova VN, Sachinidis A, Hengstler JG, Waldmann T, Leist M:

Lineage-specific regulation of epigenetic modifier genes in human liver and brain. PLoS One 9(7): e102035 (2014) (14 pp)

Rafnar T, Sulem P, Thorleifsson G, Vermeulen SH, Helgason H, Saemundsdottir J, Gudjonsson SA, Sigurdsson A, Stacey SN, Gudmundsson J, Johannsdottir H, Alexiusdottir K, Petursdottir V, Nikulasson S, Geirsson G, Jonsson T, Aben KK, Grotenhuis AJ, Verhaegh GW, Dudek AM, Witjes JA, van der Heijden AG, Vrieling A, Galesloot TE, de Juan A, Panadero A, Rivera F, Hurst C, Bishop DT, Sak SC, Choudhury A, Teo MT, Arici C, Carta A, Toninelli E, de Verdier P, Rudnai P, Gurzau E, Koppova K, van der Keur KA, Lurkin I, Goossens M, Kellen E, Guarrera S, Russo A, Critelli R, Sacerdote C, Vineis P, Krucker C, Zeegers MP, Gerullis H, Ovsiannikov D, Volkert F, Hengstler JG, Selinski S, Magnusson OT, Masson G, Kong A, Gudbjartsson D, Lindblom A, Zwarthoff E, Porru S, Golka K, Buntinx F, Matullo G, Kumar R, Mayordomo JI, Steineck DG, Kiltie AE, Jonsson E, Radvanyi F, Knowles MA, Thorsteinsdottir U, Kiemeney LA, Stefansson K:

Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. Hum Mol Genet 23: 5545-5557 (2014) [7492_IfADo.pdf] http://dx.doi.org/10.1093/hmg/ddu264